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We describe the complete sequence of the 15.9-kb
staphylococcal pathogenicity island 3 encoding staphy-
lococcal enterotoxin serotypes B, K, and Q. The island,
which meets the generally accepted definition of patho-
genicity islands, contains 24 open reading frames poten-
tially encoding proteins of more than 50 amino acids,
including an apparently functional integrase. The ele-
ment is bordered by two 17-bp direct repeats identical to
those found flanking staphylococcal pathogenicity is-
land 1. The island has extensive regions of homology to
previously described pathogenicity islands, particularly
staphylococcal pathogenicity islands 1 and bov. The ex-
pression of 22 of the 24 open reading frames contained
on staphylococcal pathogenicity island 3 was detected
either in vitro during growth in a laboratory medium or
serum or in vivo in a rabbit model of toxic shock syn-
drome using DNA microarrays. The effect of oxygen ten-
sion on staphylococcal pathogenicity island 3 gene ex-
pression was also examined. By comparison with the
known staphylococcal pathogenicity islands in the con-
text of gene expression described here, we propose a
model of pathogenicity island origin and evolution in-
volving specialized transduction events and addition,
deletion, or recombination of pathogenicity island
“modules.”
Staphylococcus aureus is a leading etiologic agent of both
nosocomial and community-acquired infections worldwide.
These infections range from fairly benign cutaneous infections,
such as furuncles, to potentially fatal diseases, including endo-
carditis and toxic shock syndrome (TSS)1 (reviewed in Ref. 1).
Its ability to cause this range of disease is due in part to its
elaboration of a vast array of both cell surface-associated and
secreted virulence factors. Among the secreted factors are the
pyrogenic toxin superantigens that have the ability to activate
large populations (10–50%) of T lymphocytes in a manner
specific to the variable region of the -chain of the T-cell recep-
tor (2). The ensuing massive cytokine release results in the
symptoms of TSS, including fever, hypotension, rash, vomiting,
diarrhea, multiple organ failure, disseminated intravascular
coagulation, and desquamation. The staphylococcal enterotox-
ins (SEs), members of the superantigen family, are associated
with both TSS and food poisoning and have proven emetic
activities that appear to be separable from their superantigenic
activity (3).
Most, if not all, staphylococcal superantigens are encoded by
accessory genetic elements that are either mobile or appear to
have been mobile at one time (reviewed in Ref. 4). These iden-
tified elements include plasmids, transposons, prophages, and
the pathogenicity islands. The staphylococcal pathogenicity is-
lands (SaPIs), of which five have, until recently, been described
(SaPI1–4 and SaPIbov), are the first clearly defined pathoge-
nicity islands in Gram-positive bacteria, and each encodes one
or more of the staphylococcal superantigens (reviewed in Ref.
5). SEB, SEC, SEK, SEL, SEQ, and toxic shock syndrome toxin
1 (TSST-1) are known to be encoded by one or more of these
phage-related elements (reviewed in Ref. 4). More recently,
Kuroda et al. (6) identified six novel pathogenicity islands in
the complete genomes of two S. aureus strains, N315 and
Mu50, including three that carried tstH (encoding TSST-1), two
that carried clusters of staphylococcal exotoxin-like proteins,
and one, present in both strains, that carried clusters of serine
proteases and enterotoxins.
These genomic loci meet the generally accepted require-
ments of the pathogenicity island subgroup of “genomic is-
lands” as defined previously (7, 8). They are present in the
genomes of many staphylococci but absent from closely related
strains, they are relatively large genomic fragments (15 kb),
they differ in GC content from the rest of the chromosome, they
are flanked by direct repeats likely generated upon insertion of
the elements into the genome, some are associated with tRNA
loci, and they possess genes coding for genetic mobility, includ-
ing conserved integrases.
The prototypical staphylococcal pathogenicity island, SaPI1,
was identified and characterized by Lindsay et al. (9) as the
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genetic element encoding TSST-1, the only superantigen to be
associated with nearly all cases of menstrual TSS. SaPI1 is
15.2 kb in length, flanked by a 17-nucleotide direct repeat,
contains a functional integrase (int) gene, and is located near
the tyrB locus in strain RN4282. It also appears to encode a
second superantigen, SEK, and part of a third superantigen,
SEQ. Mobility of SaPI1 has been demonstrated only in the
presence of a helper phage, such as 80. Ruzin et al. (10) have
demonstrated that SaPI1 appears to parasitize excision, repli-
cation, and encapsidation functions of phage 80 in a relation-
ship that is similar to that between coliphages P4 and P2.
During the growth of phage 80, SaPI1 excises from its unique
chromosomal insertion site, attc, replicates in the linear form,
interferes with phage growth, and is encapsidated into special-
ized phage heads. Upon transduction to a recipient organism,
SaPI1 integrates by the classical Campbell mechanism into the
attc site for which the SaPI1-coded integrase is necessary.
Because islands with different att sites appear to have dissim-
ilar integrases (6), it may well be that the integrase carried by
the island determines the integration site in the genome.
Existence of these toxin genes on mobile genetic elements
implies their transfer between staphylococcal strains as well as
other bacterial species by horizontal transfer. Furthermore,
these elements are not uniformly distributed among clinical
isolates. Thus, these mobile elements likely have played and
continue to play an integral role in the evolution of S. aureus as
a species and as a pathogen. Indeed, recent evidence supports
the hypothesis that virulence traits are spread by horizontal
transfer, particularly in nosocomial infections, and that the
presence of accessory genetic elements within a strain may
affect the acquisition and loss of other mobile genetic elements
(11). These islands may also form the basis for toxin gene
exclusion. For instance, in testing thousands of strains, our
laboratory has never identified a clinical isolate that produced
both TSST-1 and SEB. It has been determined that these toxins
are encoded by different pathogenicity islands that appear to
exclude each other from their respective integration sites.
However, despite the identification of numerous pathogenic-
ity islands and their likely importance in the evolution of
Staphylococcus as a pathogen, the origin and functions of patho-
genicity islands remain areas with little investigation. All of
the SaPIs have multiple open reading frames (ORFs), many
of which have no identifiable homologs. To this point, the is-
sues of whether or not these ORFs are expressed and whether
their function might be in the regulation of island-associated
superantigens or only in the maintenance and transfer of the
islands have not been addressed. In this study, we report
the complete sequence and map of SaPI3 encoding SEB and the
more recently identified enterotoxins, SEK (12) and SEQ.2
Furthermore, we describe for the first time the expression of
the numerous genes contained on a staphylococcal pathogenic-
ity island using DNA microarray technology. We then discuss
the implications for the evolution of the staphylococcal patho-
genicity islands.
MATERIALS AND METHODS
Strains—COL is a prototypical methicillin-resistant isolate of S.
aureus that is currently being sequenced by The Institute for Genomic
Research. MN NJ is a methicillin-sensitive isolate of S. aureus from a
case of nonmenstrual TSS in which our laboratory has identified two
novel superantigens, SEK (12) and SEQ.2 S. aureus MN8, also a me-
thicillin-sensitive isolate of S. aureus, was used as a source of genomic
template for amplification of virulence gene probes for the DNA mi-
croarrays and was isolated before 1980 from a case of menstrual TSS
(13).
Sequencing—Preliminary sequence data for the S. aureus strain
COL was obtained from The Institute for Genomic Research website
(www.tigr.org). A primer walking-based approach was used to amplify
by PCR and sequence 3.4 kb that spanned the unsequenced loci of
SaPI3 in the COL genomic sequence data base. Automated sequencing
using an ABI model 377 was performed with the assistance of the
Advanced Genetic Analysis Center (University of Minnesota, St. Paul,
MN).
Growth of S. aureus in vitro—50-ml cultures of S. aureus MN NJ
were grown aerobically with shaking at 37 °C in either Todd-Hewitt
(TH) broth (BC PharMingen) or rabbit serum (Invitrogen). Two inde-
pendent cultures in each medium were grown in parallel, and samples
were removed at the exponential, postexponential, and stationary
phases of growth (2, 3, and 8 h after inoculation with an initial cell
density of A600 nm  0.1). Expression of SaPI3 ORFs and other viru-
lence-associated genes was quantified using DNA microarrays.
For cultures exposed to altered oxygen levels, 1 ml of TH broth was
inoculated with S. aureus MN NJ from an overnight culture to an initial
cell density of A600 nm 0.1 in a 35 12-mm-diameter polystyrene Petri
dish (Nunc, Roskilde, Denmark). All cultures were placed into sealed,
humidified Plexiglass cell culture chambers (20  26  7.5 cm, internal
dimensions; Mishell-Dutton) (14), flushed with gas mixtures containing
either 1% oxygen (v/v) or 21% oxygen (v/v) balanced with nitrogen and
7% carbon dioxide (Praxair, St. Louis, MO), and sealed. Chambers were
then incubated at 37 °C with orbital shaking (125 rpm). Samples for
the exponential, postexponential, and stationary phases of growth were
removed at 2, 3, and 8 h after inoculation, respectively, and expres-
sion of SaPI3 genes was quantified using DNA microarrays. We have
previously determined that there is no significant difference in growth
parameters (cell densities or timing of entry into the growth phases of
interest) between cultures grown in 1% oxygen and 21% oxygen (v/v)
balanced with nitrogen and 7% carbon dioxide (15, 16).
Immunization of Dutch-belted Rabbits—Two Dutch-belted rabbits
were immunized with SEB, which is made in high concentrations (10
g/ml) by MN NJ grown in vitro. Rabbits were immunized by three
subcutaneous injections at 2-week intervals, with each injection
containing 25 g of purified SEB resuspended in 0.5 ml of phosphate-
buffered saline and emulsified in 0.5 ml of incomplete Freund’s adju-
vant. Development of antibody to SEB was determined by enzyme-
linked immunosorbent assay of serum samples taken 1 week after the
final immunization. The two rabbits developed anti-SEB (IgG) titers of
1:5,120 and 1:10,240, respectively, as compared with preimmune titers
of 1:20.
Subcutaneous Infection Model—Sterilized perforated hollow polyeth-
ylene golf balls were implanted subcutaneously in four Dutch-belted
rabbits (17). Implantation of the polyethylene balls and subsequent
healing created transudate-filled cavities in the rabbits with volumes of
15 ml that contained few host cells, thus enabling the preparation of
staphylococcal RNA relatively free of contaminating host RNA. 6 weeks
after implantation of the polyethylene balls,1010 colony-forming units
of S. aureus MN NJ grown in TH medium were collected by centrifu-
gation from the late exponential phase of growth (cell density of cul-
tures was 6.7  108 colony-forming units/ml), resuspended in 2 ml of
phosphate-buffered saline, and injected into the implanted polyethyl-
ene balls. Samples were removed from the inoculum culture before
centrifugation for use in expression analysis by DNA microarrays. 2 ml
of transudate containing S. aureus were then removed from the infec-
tion chambers at the indicated times after inoculation using a sterile
syringe, S. aureus was enumerated by plating, and expression of SaPI3
genes was quantified using DNA microarrays.
RNA Preparation and DNA Microarrays—Analysis of staphylococcal
gene expression in vitro and in vivo using DNA microarrays was per-
formed as described elsewhere (www.agac.umn.edu/microarray/proto-
cols/protocols.htm). In brief, a library of targets representing 68 genes
from S. aureus MN NJ and MN8 was constructed with primers designed
to amplify fragments of 300 bp of each gene from genomic DNA. Two
successive rounds of PCR were performed to minimize genomic DNA
contamination in the amplification products, and the final 100-l reac-
tions were checked for quality on agarose gels and purified with the
QIAquick PCR Purification Kit (Qiagen, Valencia, CA). The purified
products were printed in triplicate using a Total Array System robot
(BioRobotics, Boston, MA). Cell pellets from centrifuged samples of S.
aureus cultures were flash-frozen in liquid nitrogen. Total RNA was
prepared using the RNeasy Mini Kit (Qiagen) according to the manu-
facturer’s directions. DNA was removed from the RNA preparations
using the RNase-free DNase Set (Qiagen) according to the manufactur-
er’s directions. cDNA prepared from RNA from S. aureus cultures to be
compared was labeled with either Cy3 or Cy5 fluorescent dye (Amer-
2 P. M. Orwin, D. Y. M. Leung, H. L. Donahue, G. A. Bohach, and
P. M. Schlievert, submitted for publication.
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sham Biosciences) and competitively hybridized with the printed mi-
croarrays. Images of the hybridized arrays were obtained with a
Scanarray 5000 microarray scanner (GSI Lumonics, Watertown, MA).
One independent hybridization (on triplicate arrays) was conducted for
each of two independent experiments. Fluorescence intensities for in-
dividual spots were normalized based on the total intensity of fluores-
cence in the Cy3 and Cy5 channels. Fluorescence intensity was deter-
mined as the average intensity of the triplicate spots for each gene.
Total fluorescence for each gene was normalized between arrays for
independent experiments, the data were combined from both experi-
ments, and statistical significance was determined using Student’s t
test to compare expression data from the two growth conditions of
interest. SaPI3 ORFs were determined as being expressed if the fluo-
rescence intensity was at least twice that of background levels estab-
lished using negative controls (probes for genes not expressed by strains
MN NJ and COL) and if fluorescence was detected in each of the
triplicate arrays for each independent experiment. To account for pos-
sible bias in labeling of cDNA by either Cy3 or Cy5, dye labeling was
reversed in the second independent experiment for each of several
experimental conditions. No dye bias was detected. Clustering based on
similarity of expression profiles and visualization were performed using
the software program Spotfire DecisionSite 6.1 (www.spotfire.com).
Similarities between expression profiles of individual genes in all 11
experimental conditions were calculated using the “Euclidean distance”
method.
RESULTS
Identification and Characterization of SaPI3—Data base
searches of the unfinished S. aureus COL genome (www.tigr.
org) revealed the presence of large segments homologous to
SaPI1. Because COL does not produce TSST-1, we hypothe-
sized that this sequence comprised a novel pathogenicity is-
land, which we termed SaPI3. Using the SaPI1 sequence and
SaPI3 partial sequence as guides, primers were designed to
complete the sequence of SaPI3 in the COL strain. In all, a PCR
and primer walking-based approach was used to sequence3.4
kb of the 15,936-bp SaPI3. SaPI3 was determined to have 24
ORFs potentially encoding proteins over 50 amino acids in
length, 3 of which encoded staphylococcal enterotoxin serotypes
B, K, and Q, and many of which have homologs in SaPI1 and
SaPIbov (Fig. 1; Table I). We were also able to identify the
presence of SaPI3 in the clinical isolate S. aureus MN NJ, a
known SEB producer, by PCR analysis and sequencing of the
same three regions as in strain COL (data not shown). MN NJ
is an isolate from a case of nonmenstrual TSS in which our
laboratory has described the presence of two novel enterotox-
ins, SEK (12) and SEQ.2 The repeated 17-nucleotide sequences
flanking SaPI3 were identical to the att sites of SaPI1 (5-
TTATTTAGCAGGATAA-3) and thus might form the basis of
pathogenicity island exclusion (i.e. the lack of TSST-1 and SEB
in the same clinical isolates). In general, the identified SaPI3
genes form two apparent transcriptional blocks with ORFs
2–18 (including SEB) oriented toward the left of the island,
whereas ORFs 19–24 (including SEK and SEQ) are oriented to
the right (Fig. 1). The overall GC content of SaPI3 was 31.4%,
somewhat lower than the 32.8–32.9% found for the whole ge-
nome of S. aureus (6).
We have identified genes in SaPI3 according to the following
nomenclature: pathogenicity island_ORF number (variant).
Thus, the ninth ORF in SaPI3 is identified by the gene name
sapi3_9. A mutant of this gene might be designated as sapi3_9(1).
Sequential genes are identified using a hyphen (e.g. sapi3_10-15
is used to identify all SaPI3 ORFs from 10 through 15). Upon
determination of the gene’s function, the name will be altered to
reflect that function, such as sapi3_int. (Exotoxins on the islands
are identified according to their own nomenclature system.) If
additional genes are identified on the island subsequent to its
initial sequencing, those genes will be numbered sequential to
those already identified, rather than renumbering all of the
genes on the island. We have implemented this nomenclature
system in our laboratory to promote systematic identification of
SaPI genes, preclude confusion regarding identically numbered
ORFs on different islands, and allow unambiguous assignation of
expression data to SaPI genes.
A comparison of SaPI3, SaPI1, and SaPIbov is shown in Fig.
1, and the corresponding ORFs are identified in Table I. The
overall length of the three SaPIs is similar, although SaPIbov
is larger on the 5 end by 1915 bp. SaPIbov also has a different
att site than SaPI1 and SaPI3. Two core regions of high (92%
identity) homology between all three islands were identified
(Fig. 1). The first core region includes nucleotides 2974–6709 of
SaPI1, 3113–6929 of SaPI3, and 5100–8745 of SaPIbov.
Within this core region, SaPI1 has an additional 100 bp not
present in SaPIbov (nucleotides 5909–6009 in SaPI1), whereas
FIG. 1. Comparative map of pathogenicity islands 3 (SaPI3), 1 (SaPI1), and bov (SaPIbov). Arrows represent the location and
orientation of open reading frames or previously described genes greater than 50 amino acids in length. Regions of sequence homology greater than
92% between the islands are indicated by shading. Genes encoding enterotoxins B (seb), K (sek), Q (seq), and the bovine variant of C (sec-bov) are
indicated. Seq potentially encodes a truncated enterotoxin L. sapi3_1 (ear) encodes a putative -lactamase-like protein. Also shown are the likely
integrase genes (int) as well as the attachment (att) sequences. Stem-loop structures that may serve as rho-independent transcription terminators
are indicated for SaPI3 (predicted using DNA Strider version 1.2).
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SaPI3 contains this 100-bp stretch as well as an additional 67
bp not present in either SaPI1 or SaPIbov (nucleotides 6063–
6230). The second core region includes nucleotides 9380–
10,284 of SaPI1, 9591–10,494 of SaPI3, and 11,419–12,429 of
SaPIbov. All three islands contain int genes adjacent to the
attR sites, and SaPI3 contains an enterotoxin gene (seb) in the
same position as tstH in SaPI1 and SaPIbov. SaPI1 and SaPI3
appear to be even more closely related. In addition to the
shared elements among all three islands and the identical
attachment sites in SaPI1 and SaPI3, these two islands are
highly homologous (93% identity) at the right end (nucleo-
tides 10,285–11,046 in SaPI1 and 10,494–11,254 in SaPI3;
nucleotides 12,248–15,250 in SaPI1 and 12,891–15,953 in
SaPI3) (Fig. 1). The ear (sapi1_1 and sapi3_1) and sek genes are
also in the same relative positions to each other and to the att
sites of SaPI1 and SaPI3. Although the function of ear is
unknown, several properties of the gene suggest that it may
have an important function in the life cycle of S. aureus. Its
position and predicted product are conserved (75% identity at
the amino acid level) among SaPI1, SaPI3, and SaPI4 (data not
shown), it has the identical signal sequence as TSST-1, and it
is secreted in abundant quantities by S. aureus RN4282. In
addition to homology between SaPI1, SaPI3, and SaPIbov, the
region encoding sapi3_3-9 and sapi3_15 shares extensive ho-
mology (95% at the nucleotide level) to a matching region in
SaPIn1/SaPIm1, whereas sapi3_10-14 are 87% or more similar
to regions presumably of phage origin in strain Mu50.
A locus of900 bp adjacent to the attL site of SaPI3 was 95%
identical to a phage 80 sequence adjacent to the putative
phage amidase gene. However, this region of SaPI3 apparently
does not encode for any protein. A 1.6-kb region SaPI3 with
significant variance as compared with SaPI1 is found spanning
the region between sapi3_17 and seq. Within this region is a
stretch of 500 nucleotides that is nearly identical to a se-
quence from the recently identified SLT, a temperate S. au-
reus phage encoding the Panton-Valentine leukocidin. Imme-
diately upstream of int in both SaPI1 and SaPI3 is a 46-bp
sequence conserved among staphylococcal phages 11, 13,
42, and L54a (18–20). This sequence is the binding site for
two phage 11 proteins that regulate int expression, RinA and
RinB (21).
In addition to the integrase and the noncoding regions with
homology to phage DNA, several of the genes contained on
SaPI3 suggest a mobile element of phage origin, perhaps a
conglomeration of several phage elements (Table I). The termi-
nase potentially encoded by sapi3_3 is homologous to the small
subunit of identified terminases in the bacteriophages 15 (22)
(52% similarity over 162 amino acids) and PBSX of Bacillus
subtilis (23) (50% similarity over 102 amino acids). Sapi3_12
potentially encodes a product with high homology (54% simi-
larity over 333 amino acids) to the virulence-associated protein
(VapE) of Dichelobacter nodosus, a sheep pathogen (24).
(Sapi1_11 is also a VapE homolog 9.) This has led to the
supposition that this gene was acquired by S. aureus through
horizontal transfer from D. nodosus during co-colonization or
infection of sheep (5) because the D. nodosus vap genes appear
to reside on an integrated bacteriophage (25, 26). The predicted
product of sapi3_18 is 75% similar over 58 amino acids to a
putative cro-like repressor of Streptococcus thermophilus bac-
teriophage Sfi21 (27, 28). Even stronger homology is seen be-
tween the predicted product of sapi3_19 and the cI-like repres-
sor of S. thermophilus phage Sfi21 (27, 28) (84% similarity over
67 amino acids) and Lactobacillus casei phage A2 repressor
(29) (80% similarity over 76 amino acids). Sapi3_20 potentially
encodes a glycoprotein similar to one found in bacteriophage
A118 (30) (54% similarity over 123 amino acids) and is strongly
similar to ORF 135 from the recently described S. aureus
temperate phage SLT carrying Panton-Valentine leukocidin
(31) (85% similarity over 153 amino acids).
Expression Analysis of SaPI3—Studies of pathogenicity is-
lands in other bacterial species have demonstrated that genes
contained on the islands act in regulation of virulence factors
carried by the island (reviewed in Ref. 7). SaPI3 contains sev-
eral ORFs with no identifiable function, and it was not known
whether or not they were expressed, and, if so, whether they
might act in regulation of the SaPI3 enterotoxins, seb, sek, and
TABLE I
Description of SaPI3 ORFs
Name Length
Predicted
molecular
massa
Corresponding
ORF in
SaPI1b
Corresponding
ORF in
SaPIbov
Description (homolog)
Expression
detected in
vitro
Expression
detected in
vivo
(amino acids) (kDa)
sapi3_1/ear 185 20.2 1 (ear) sel Y Y
seb 266 31.4 sec Enterotoxin Y Y
sapi3_3 183 20.7 2 5 (Terminase) Y
sapi3_4 113 13.4 3 6 Y
sapi3_5 175 20.6 4 7 Y
sapi3_6 72 8.2 5 8 Y Y
sapi3_7 192 22.8 6 9
sapi3_8 113 13.4 10 Y
sapi3_9 213 24.5 7 11 Y
sapi3_10 94 10.8 8
sapi3_11 120 13.9 12 Y
sapi3_12 474 55.0 11 (vapE) Y
sapi3_13 289 33.3 13/12 15 (Replication protein) Y
sapi3_14 106 12.7 16 Y Y
sapi3_15 69 8.3 Y Y
sapi3_16 55 6.0 Y Y
sapi3_17 90 10.4 14 (ORF 37 S. aureus
phage PVL)
Y
sapi3_18 66 7.6 (Cro-like repressor) Y Y
sapi3_19 110 12.7 (cI-like repressor) Y Y
sapi3_20 152 18.1 (ORF 153 of SLT) Y Y
sapi3_21 143 16.2 (ABC transporter) Y Y
seq 242 28.2 seq Enterotoxin Y Y
sek 242 27.7 sek Enterotoxin Y Y
sapi3_int 407 47.6 int int Integrase Y Y
a Determined using the Compute pI/Mw tool at ca.expasy.org/tools/pi_tool.html (51).
b Corresponding ORFs were determined by relative position within the islands and/or similarity of the predicted gene products.
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seq, or only in the maintenance and transfer of the island itself.
We thus used DNA microarrays to examine the expression of
all SaPI3 ORFs potentially encoding products over 50 amino
acids in size to determine whether or not they were detectably
expressed and whether their expression profiles were similar to
those of the SaPI3-associated enterotoxins. DNA primers used
to PCR-amplify probes for each ORF are listed in Table II.
Expression data for SaPI3 genes in various growth condi-
tions are summarized in Table III. Because staphylococcal exo-
toxins are generally growth phase-regulated, we first examined
the effect of growth stage on the expression of SaPI3 genes. In
all, the expression of 13 of 24 ORFs was detected during growth
of MN NJ in TH broth. The expression of five of these genes was
significantly (p  0.05, Student’s t test) altered by postexpo-
nential growth as compared with exponential phase growth,
whereas the expression of four genes was affected by stationary
phase growth. As expected, the expression of seb, known to be
a postexponential and stationary phase-produced exotoxin, was
increased by 8.2-fold in stationary phase as compared with the
exponential phase of growth. Interestingly, the expression of
sek and seq was unaffected by growth phase, suggesting that
these are constitutively produced exotoxins in laboratory
media.
Previous studies have demonstrated repression of another
staphylococcal toxin associated with TSS, TSST-1, by anaerobic
conditions and enhancement of toxin production in aerobic
conditions, particularly in the presence of elevated carbon di-
oxide (15, 32–35). Our laboratory has also determined that the
effect of oxygen on tstH expression occurs primarily at the
transcriptional level and is independent of cell density and pH
(15).3 To examine the effect of oxygen concentration on the
expression of SaPI3 genes, the cultures were exposed to mi-
croaerobic (1% O2 (v/v)) and aerobic (21% O2 (v/v)) growth
conditions in 1-ml cultures of TH broth. There was no signifi-
cant difference in growth parameters between the microaerobic
and aerobic cultures because both cultures entered their re-
spective growth phases (exponential, postexponential, and sta-
tionary) of interest at similar times. Also, differences in cell
densities between the microaerobic and aerobic cultures were
2-fold or less in any given growth phase. In all, the expression
of 18 of the 24 SaPI3 ORFs was detected. The expression of
four, four, and three genes was significantly affected by growth
in microaerobic conditions in the exponential, postexponential,
and stationary phases of growth, respectively. The expression
of seb was somewhat repressed in the exponential and postex-
ponential phases of growth in aerobic conditions and was
slightly up-regulated during stationary phase growth in aero-
bic conditions. The expression of no gene, however, was affected
by more than approximately 2-fold.
To approximate in vivo conditions and determine those genes
whose expression might be artificially enhanced by growth in
rich laboratory medium, the expression of SaPI3 genes was
examined during growth of MN NJ in TH broth versus rabbit
serum. Effect of growth in serum was examined in the expo-
nential, postexponential, and stationary phases of growth.
Cells were quantified by both absorbance and dry weight. No
difference in the time at which TH or serum cultures entered
their respective growth phases of interest was observed.
A600 nm values for S. aureus grown in TH medium were 0.83,
1.69, and 2.16 for the exponential, postexponential, and sta-
tionary phases of growth, respectively. A600 nm values for S.
aureus grown in rabbit serum were 0.33, 0.97, and 1.27 for the
same growth phases. As measured by dry weight, cell mass at
8 h was 8.0 mg/ml in TH medium and 8.3 mg/ml in rabbit
serum. Quantification of S. aureus growth in serum in vitro is
problematic because cells clump tightly and are resistant to
dispersal, even by ultrasonication, thus preventing accurate
counts by plating or absorbance. Alternatively, dry weight
analysis is hampered by the tendency of S. aureus to bind
serum components and thus add ”artificial“ cell mass. Thus, an
effect of cell density on SaPI3 gene expression cannot be ruled
out in these serum cultures. Taken as a whole, however, the
data reflect the fact that growth in standard rich laboratory
media may well enhance or repress expression of virulence-
associated genes in a manner inconsistent with what occurs in
vivo. In all, the expression of 19 of 24 SaPI3 ORFs was detected
in these experiments. The expression of five, six, and three
genes were affected by growth in serum as compared with TH3 J. M. Yarwood and P. M. Schlievert, unpublished observations.
TABLE II
Primers used to PCR-amplify SaPI3 microarray probesa
Gene name Forward primer (5-3)b Reverse primer (5-3)c
sapi3_1/ear GTAGTATTACGGGTACAGC gatcggatccTTATTTAGTTATAGTTATTTTTG
seb GAAGTATTACTGTTCGGG gatcggatccTCACTTTTTCTTTGTCGTAA
sapi3_3 ATGAAACAGAAACGAAAG gatcggatccTCAATCCTCTAACGGAATA
sapi3_4 GATCCCATGGCTATGGATAAAAAGCAAATAAAA gatcggatccTCTATCACCTCCACAATTTT
sapi3_5 CCATGGCTATGAGTGCGTCGACCAC gatcggatccCTAACTGTTTTCAATTGCT
sapi3_6 CCATGGCTATGGAAACAAAATGCGAG gatcggatccCTATTTAATAATCCTGTTTTG
sapi3_7 AGACAATTGAATTATTAAAACA gatcggatccTTAACGTTTTAAAAACAACTTG
sapi3_8 CCATGGCTATGCAAAGTATCGCAGAA gatcggatccTTACACTTTAATTCGTTTCA
sapi3_9 ATGATGGCCAGTCAATTG gatcggatccTTATTTACTCAAGCTATAGT
sapi3_10 CCATGGCTATGAATGATAAAGAGAAAATTT gatcggatccTGTGTTATCTCCTTTTGAG
sapi3_11 CCATGGCTATGAATAAAAATCAATTAAAGTC gatcggatccTTAGACACACTCCGTTTC
sapi3_12 TGGTATAGAACGTTAGAAG gatcggatccTTAAACTTTAAGATTCTTATAA
sapi3_13 GTTGATATGCTCGAACAG gatcggatccCTAACTGTTTTTACTATCTT
sapi3_14 ccatggctATGAATTGGGAAATTAAAGA gatcggatccTTACTCTGCTACTTTTATTG
sapi3_15 ccatggctATGAATAATGAACAAAAAGAA gatcggatccTTATTCTCCTTTCTCTAATT
sapi3_16 ccatggctATGGATGTAGGAGGCAAG gatcggatccTTATTCATTTTCTAATCCTCC
sapi3_17 ccatggctATGTCTAGAACAAAATTGCAT gatcggatccCTACATCCATTTTTTATGAC
sapi3_18 ccatggctATGGCTCACAAAATGGGG gatcggatccCTAGACATTTAATTCACCTC
sapi3_19 ccatggctATGAGAACTAATGATGAAAT gatcggatccTTACTGATTTCGATGTGCTT
sapi3_20 ACGAAGAACTTGCCCAC gatcggatccTTATATTTCTTTATATTTAAAAAC
sapi3_21 AAGATAATAAATTAAATGTTATC gatcggatccTCACTTTAATGTTTTATCCAT
seq AAGAGGTAACTGCTCAAG gatcggatccTTATTCAGTCTTCTCATATG
sek ACCGCTCAAGAGATTGAT gatcggatccTTATATCGTTTCTTTATAAGAA
sapi3_int ATTCAAAATGGAATGATGGA gatcggatccTTATCCAAGTTTTACCTGT
a The forward direction for each primer pair was determined by the orientation of the corresponding gene.
b Some forward primers incorporate a NcoI restriction site (lowercase characters).
c Reverse primers incorporate a BamH1 restriction site (lowercase characters).
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medium in the exponential, postexponential, and stationary
phases of growth, respectively, although no gene was affected
by more than 3.3-fold. In general, expression of genes on either
end of the island was more consistently detected than
sapi3_7-17.
Finally, we examined the expression of SaPI3 genes during
incubation of MN NJ in vivo in a rabbit model of TSS using
subcutaneous hollow polyethylene infection chambers (17, 36).
The expression of SaPI3 genes in vivo was compared with that
in the inoculum, which was harvested from cultures in the late
exponential phase of growth and used to infect both nonim-
mune rabbits and rabbits immunized with SEB. All animals
developed symptoms consistent with TSS, including hypoten-
sion, respiratory distress, and obvious discomfort in the vicinity
of the infection chamber. The SEB-immunized rabbits experi-
enced a delayed onset of symptoms and were euthanized 22 h
after inoculation, whereas the nonimmune rabbits died several
hours after inoculation. Cell densities recovered from the in-
fection chambers did not vary more than 0.22 log units from the
cell density of the inoculum before concentration (6.7  108
colony-forming units/ml), thus we were able to effectively elim-
inate the potential effects of cell density and growth phase on
gene expression in vivo. Using this subcutaneous infection
model, we were previously able to demonstrate up to 18-fold
changes in virulence-associated gene expression between cells
in the inoculum and cells in vivo (36). The expression of 13 of 24
SaPI3 ORFs was detected in vivo. Sapi3_1 (ear) and seb were
significantly up-regulated during incubation in vivo in the non-
immune rabbits as compared with the inoculum and were
affected very little by incubation in the immune animals. The
expression of sek and seq was only significantly affected by
incubation of MN NJ in the immune animals at 8 h, in which
case they were repressed, together with sapi3_20, sapi3_21,
and sapi3_24.
To determine whether any of the genes contained on SaPI3
might act in the regulation of or be co-regulated with the
enterotoxins carried by the island, the genes were clustered
according to the similarity of their expression profiles (Fig. 2).
The expression profiles of the secreted toxin -hemolysin (hla)
and the surface molecule protein A (spa) in these experimental
conditions are provided as representative virulence factors. To
our knowledge, the presence and expression of hla and spa are
not affected by the presence of SaPI3 or any of the other
described pathogenicity islands. Three primary clusters of
SaPI3 genes were observed. The expression profile of seb
matched most closely with that of hla and not any of the other
SaPI3 genes. In contrast, the expression of sek and seq was
found to be most similar to that of the surrounding genes
(sapi3_19-21 and sapi3_24). This clustering of sapi3_19-24 in
their expression profiles is suggestive because the direction of
transcription of these genes is opposite that of nearly all of the
remaining genes (sapi3_2-18) on SaPI3. Finally, those genes
centrally located in the island (sapi3_3-18, with the exception
of sapi3_6), whose expression was detected only in a limited
number of growth conditions, form a third group with variable
expression patterns. Although it was consistently detected,
FIG. 2. Expression profiles and hierarchical clustering of the genes for -hemolysin (hla) and protein A (spa) and the 24 SaPI3
ORFs potentially encoding products of more than 50 amino acids. Red and green represent fold decrease and increase, respectively, in gene
expression in response to later growth phase (lanes 1 and 2), growth in microaerobic versus aerobic conditions (lanes 3–5), growth in rabbit serum
versus laboratory medium (lanes 6–8), and incubation in vivo as compared with the inoculum (lanes 9–11). Gray shading indicates those ORFs
whose expression was not detected in the corresponding growth condition. Clustering based on similarity of expression profiles and visualization
were performed using the software program Spotfire DecisionSite 6.1 (www.spotfire.com). Similarities between expression profiles of individual
genes in all 11 experimental conditions were determined using the Euclidean distance method. exp, exponential; post-exp, postexponential; stat,
stationary.
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sapi3_1 (ear) did not group with any of the other genes
examined.
Although the resolution of these array experiments did not
allow a conclusive determination that any of the SaPI3 genes
are co-transcribed, the proximity of several ORFs to one an-
other and the clustering of their expression profiles are sug-
gestive. For instance, sapi3_4 and sapi3_5, which are sepa-
rated by only 2 nucleotides, cluster together, as do sapi3_19
and sapi3_20, separated by 11 nucleotides. Interestingly,
sapi3_21 and seq, separated by 11 nucleotides, also have sim-
ilar expression profiles. Genes sapi3_9-11 form a set of over-
lapping or nearly overlapping ORFs, but their expression was
not detected in a sufficient number of conditions to make a
conclusion regarding their possible co-transcription. Genes
sapi3_14-18 also form a set of overlapping or nearly overlap-
ping reading frames; however, only sapi3_15 and sapi3_16,
which overlap by 13 nucleotides, cluster in their expression
profiles. The presence of co-transcribed genes would not be
unexpected if the pathogenicity island was indeed of phage
origin. Co-transcribed genes are common in phage genomes
because numerous products, such as structural elements, are
encoded by polycistronic transcripts to achieve coordinate tem-
poral regulation at critical points within the phage lytic cycle.
The presence of several stem-loop structures that may serve as
rho-independent transcription terminators is indicated in Fig.
1. The placement of these structures is consistent with those
genes that are known or likely to be independently transcribed,
such as seb, sapi3_1 (ear), sek, and int, as well as with those
genes that may well be co-transcribed, such as sapi3_14-18.
In all, we were able to detect the expression of 22 of the 24
SaPI3 ORFs by microarray analysis (Table I). 13 ORFs were
detectably expressed in vivo and in vitro, 9 ORFs were detect-
ably expressed in vitro only, and 2 ORFs were not detectably
expressed in any growth condition examined. The expression of
genes toward either end of SaPI3 was more consistently de-
tected than that of genes contained in the central region of the
island. Consistent with a role for these islands in dissemination
of staphylococcal enterotoxins, the expression of the toxins seb,
sek, and seq was consistently detected under multiple growth
conditions.
DISCUSSION
In the work presented here, we have described a novel path-
ogenicity island, SaPI3, in S. aureus strains COL and MN NJ.
We propose that the newly identified island meets the consen-
sus definitions of a pathogenicity island (7), including the pres-
ence of demonstrated virulence genes on the island (seb, sek,
and seq), the lack of the island in closely related strains, the
occupation of a relatively large genomic region (16 kb), a
lower GC content than the overall S. aureus genome (31.4%
versus 32.8%), the presence of flanking direct repeats, and the
presence of mobility factors (integrase). Many of the genes
contained on the island are homologous to genes contained on
described bacteriophages, suggesting that this SaPI, like
others described previously, is of bacteriophage origin. Fur-
thermore, we have detected the expression of 22 of the 24 genes
contained on the island, suggesting that many of them may be
active in the maintenance of the island or in regulation of the
associated enterotoxins.
Several explanations for the origin of the staphylococcal
pathogenicity islands are possible. A large number of pathoge-
nicity islands may circulate through the combined gene pool of
numerous bacterial species with which staphylococci is tran-
siently associated, in or on its human and animal hosts, and
from which staphylococci acquires these elements through hor-
izontal transfer. However, this hypothesis seems unlikely be-
cause superantigen production has been identified in a very
limited number of bacterial species, suggesting that these ele-
ments are not in general circulation. The possibility cannot be
eliminated completely, however, until the genomes of currently
unidentified bacterial associates of staphylococci are character-
ized. A second hypothesis suggests that exotoxins are carried
primarily by other genetic elements, such as plasmids and
phage, and have integrated into sites of high recombination
frequency in one more ancestral strains. These recombination
events might be mediated by homologous genes in the acces-
sory genetic elements and the pathogenicity island, giving rise
to the exotoxin-carrying islands. However, this hypothesis does
not account for the origin of superantigen genes on transmis-
sible elements, the apparently exclusive presence of certain
superantigen genes on only pathogenicity islands, and the
likely role for the demonstrably mobile pathogenicity islands in
dissemination and evolution of superantigens. A third hypoth-
esis, which we favor, combines certain elements of the first two,
with the addition of the assumption of a common ancestral
genetic element to SaPI1–4, SaPIbov, and SaPIm1/SaPIn1 and
the continual generation of unique toxins and islands through
modular recombination events.
Several features of the enterotoxin-encoding pathogenicity
islands identified thus far suggest a common ancestral genetic
element and that these islands have arisen in part through
specialized transduction and recombination events. The overall
layout of the islands, even specific genes, is similar, with exo-
toxins encoded on either end of the islands (the location of tstH
is nearly identical in SaPIn1/SaPIm1, SaPI1, and SaPIbov),
and the exotoxin genes on the right end of the islands consis-
tently located upstream of the integrase genes. Toward the
center of the islands lie multiple genes of apparently phage
origin. Furthermore, the region in SaPI3 between nucleotides
3113 and 6929 and nucleotides 9591 and 10,494 is nearly
identical to regions in all of these islands. Thus, we propose a
generalized model for the origin and evolution of staphylococcal
pathogenicity islands (Fig. 3). The presence of the exotoxin
genes on the left ends of the islands can be explained by a
specialized transduction event involving an ancestral, exotox-
in-free bacteriophage in either Staphylococcus or a bacterial
species with which Staphylococcus has subsequently engaged
in horizontal gene transfer. In this model, a bacteriophage
element excised from the chromosome adjacent to a superanti-
gen locus and through a mis-recombination event gained the
enterotoxin while either simultaneously or subsequently losing
a segment of phage DNA necessary for complete phage function
(such as xis). It thus became dependent upon wild-type helper
phage for excision, packaging, and/or mobilization, as observed
with SaPI1. Indeed, the expression of seb, which is known to be
regulated by the staphylococcal accessory gene regulator (agr)
in vitro, did not correlate with the expression of any other gene
contained on the island but rather correlated with the agr-
regulated gene hla, which is not associated with SaPI3. This
supports the hypothesis that these exotoxins were incorporated
into an existing phage.
The presence of exotoxins on the right end of the island,
inside the integrase, may instead be due to addition, deletion,
or mutual crossover of large pathogenicity island fragments or
“modules.” The hypothesis of modular recombination events
perhaps mediated by key regions of sequence homology is sup-
ported by both the presence of long stretches of homology
between distinct regions of the islands and the expression data
described in this work. Extensive regions of very high similar-
ity (95% identity), such as that between SaPI3 and SaPI1, are
abruptly interrupted by regions with very little homology be-
tween the islands. Some of these regions appear to be derived
from phages such as Panton-Valentine leukocidin-converting
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phage SLT. Furthermore, SaPI1 and SaPI3 appear to have
lost the sel/sek/sec3 module present on SaPIn1/SaPIm1 and
SaPIbov, or, alternatively, SaPIn1/SaPIm1 and SaPIbov have
gained these elements after diverging from a common ancestor.
In addition, we found that we could consistently detect expres-
sion of genes on either end of the island, particularly sapi3_19-
24. However, the “core” bacteriophage genes were much more
difficult to detect and may only be strongly expressed upon
mobilization of the island. Although most of these central genes
have no definite homolog, they may well encode proteins in-
volved in the structural components of the original phage. In
phage , for instance, genes encoding head and tail components
are located together at the end of the prophage opposite the int
and xis genes (37). Thus, these genes may only be expressed
when the pathogenicity island is mobilized. Alternatively, the
promoter regions for these genes may be defective or even
absent, preventing the expression of these genes at any time
and requiring the structural components of a helper phage for
transfer. The observation, then, that sapi3_19-24 are tran-
scribed opposite to sapi3_3-18 and cluster in their expression
profiles implies co-regulation of these genes and the addition of
this enterotoxin module to the already existing pathogenicity
island. Interestingly, the DNA sequence containing sapi3_3-17
is highly conserved between SaPI1 and SaPI3 and, to a lesser
extent, SaPIbov. It is not yet clear whether the size and type of
these modules might be constrained by recombination events
that require conserved stretches of DNA sequences in the
phage genomes or are more or less randomly generated. The
possibility also cannot be excluded that staphylococcal patho-
genicity islands have arisen in part as a result of horizontal
transfer from another species. Indeed, streptococcal pyrogenic
exotoxin A, a phage-encoded superantigen, appears to be more
closely related to staphylococcal enterotoxins SEB, SEC3, and
SEG, than other streptococcal superantigens (4).
We also propose that the promiscuity of these islands and
their tendency to undergo recombination events underlie the
evolutionary divergence of staphylococcal superantigens. The
presence of an ancestral island in multiple staphylococcal lin-
eages undergoing separate genetic events (e.g. point mutations,
genetic rearrangements, and insertion of other mobile genetic
FIG. 3. A generalized model for the origination and evolution of staphylococcal pathogenicity islands. A rare excision error by a fully
functional bacteriophage leads to the addition of an ancestral exotoxin (SEn) gene to the phage genome and loss of critical phage functions. The
defective phage, now dependent on helper phage for transfer into recipient strains, undergoes divergent evolution in multiple staphylococcal
lineages. Distinct enterotoxins arise, and integration sites may be altered through evolution of the integrase genes. As distinct pathogenicity
islands then insert into identical host strains, addition, deletion, and recombination of large segments or modules of the pathogenicity islands
occur. The cycle is repeated in various permutations as the resulting pathogenicity islands then undergo further divergent evolution in subsequent
staphylococcal lineages. int, integrase gene; SE, enterotoxin gene; , phage element.
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elements) and evolutionary pressures in various communities
and hosts would lead to a great diversity of exotoxin genes as
well as pathogenicity islands (Fig. 3). Further recombination
events upon mixing of these various staphylococcal lineages
would lead to even greater diversity among the pathogenicity
islands and perhaps other mobile genetic elements as well.
However, the evolutionary fitness that superantigenic toxins
confer to the recipient strains is not yet completely understood.
It is clear that these superantigens have significant immu-
nodeletory effects, including inducing anergy and deletion of a
large population of T cells (38–40) as well as preventing the
development of antibody to the toxin itself (41–44). There is
also evidence that superantigens destroy endothelial cells (45)
and that they may exclude neutrophils from infection foci (46–
48). Thus, superantigens likely confer immunological protec-
tion to their host strains and perhaps prevent clearance of
those strains from the human host.
The demonstrated mobility of SaPI1 and the presence of
apparently functional integrases in all of these islands (5, 9, 10)
provide further support for the hypothesis that they remain a
significant part of the evolutionary scheme of S. aureus and
will likely give rise to new enterotoxins and pathogenicity
islands. The mobility of SaPIs has led to speculation that these
islands represent relatively “young,” recently acquired genetic
elements, as opposed to islands that likely entered their host
organisms millions of years ago and have become relatively
immobile, perhaps even part of the host core genome (7). Al-
ternatively, the ability of staphylococci and their associated
pathogenicity islands to evolve may be constrained by the evo-
lution of their human hosts. Thus, the conversion of any par-
ticular SaPI into a stable element may be restricted by the need
to constantly respond to the adaptive human immune response.
Constant generation of new superantigens and pathogenicity
islands might enable S. aureus to colonize and infect human
populations that may already have acquired immunity to an-
cestral exotoxins. Indeed, lack of antibody to exotoxin is a key
risk factor for the development of staphylococcal TSS (41, 49,
50).
As additional S. aureus genome sequences and SaPIs become
available and are associated with various staphylococcal lin-
eages and infection types, it may become easier to identify a
common ancestor of staphylococcal pathogenicity islands and
superantigens. Regardless, continued research into the mech-
anisms of superantigen and SaPI evolution and acquisition will
allow more accurate epidemiological investigations as well as a
greater understanding of which potential therapeutic interven-
tions might be viable, particularly in the development of toxoid
vaccines.
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